Clinical Outcomes of Erythropoietin Use in Heart Failure Patients With Anemia of Chronic Kidney Disease

Abstract Background Anemia and chronic kidney disease are common disorders in heart failure (HF) patients and are associated with increased morbidity and mortality. This study assessed clinical outcomes associated with erythropoietin (EPO) treatment in this cardiorenal anemia syndrome (CRAS) populat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cardiac failure 2014-05, Vol.20 (5), p.327-333
Hauptverfasser:	Jackevicius, Cynthia A., BScPhm, PharmD, MSc, BCPS, Fan, Cindy Shutieng, PharmD, Warner, Alberta, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Anemia - diagnosis Anemia - drug therapy Anemia - epidemiology Cardiac Cardiovascular Cohort Studies Disease-Free Survival Erythropoietin - therapeutic use Female health policy Heart Failure - diagnosis Heart Failure - drug therapy Heart Failure - epidemiology Humans Male Middle Aged outcome research Renal Insufficiency, Chronic - diagnosis Renal Insufficiency, Chronic - drug therapy Renal Insufficiency, Chronic - epidemiology Retrospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!